These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 27028966)
1. Efficacy of Long-Acting Injectable Antipsychotics in Adolescents. Pope S; Zaraa SG J Child Adolesc Psychopharmacol; 2016 May; 26(4):391-4. PubMed ID: 27028966 [TBL] [Abstract][Full Text] [Related]
2. Long-Acting Injectable Antipsychotics in Children and Adolescents. Lytle S; McVoy M; Sajatovic M J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):2-9. PubMed ID: 28112539 [TBL] [Abstract][Full Text] [Related]
3. Long-Acting Injectable Atypical Antipsychotic Use in Adolescents: An Observational Study. Fortea A; Ilzarbe D; Espinosa L; Solerdelcoll M; de Castro C; Oriolo G; Sugranyes G; Baeza I J Child Adolesc Psychopharmacol; 2018 May; 28(4):252-257. PubMed ID: 29381388 [TBL] [Abstract][Full Text] [Related]
4. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder. Wu CS; Hsieh MH; Tang CH; Chang CJ J Affect Disord; 2016 Jun; 197():189-95. PubMed ID: 26994437 [TBL] [Abstract][Full Text] [Related]
6. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists]. Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914 [TBL] [Abstract][Full Text] [Related]
7. Initiation of Aripiprazole Lauroxil Long-Acting Injectable in Adolescents During Hospitalization: A Case Series. Moon E; Kim E; Williams A J Child Adolesc Psychopharmacol; 2023 Dec; 33(10):433-438. PubMed ID: 37910863 [No Abstract] [Full Text] [Related]
8. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine]. Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790 [TBL] [Abstract][Full Text] [Related]
9. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review. Barzman DH; DelBello MP; Kowatch RA; Gernert B; Fleck DE; Pathak S; Rappaport K; Delgado SV; Campbell P; Strakowski SM J Child Adolesc Psychopharmacol; 2004; 14(4):593-600. PubMed ID: 15662152 [TBL] [Abstract][Full Text] [Related]
10. Long-Acting Injectable Antipsychotic Initiation in Child and Adolescent Patients with Psychiatric Disorders. Sun C; Temelie A; Goulding H; Clark C; Yabs M; Fabian T J Child Adolesc Psychopharmacol; 2024 Aug; ():. PubMed ID: 39180437 [No Abstract] [Full Text] [Related]
11. Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit. Gilbert JL; Nelson LA; Kriz CR; Liu Y; Iuppa CA; Diefenderfer LA; Elliott ESR; Sommi RW Psychopharmacol Bull; 2019 Jun; 49(2):8-16. PubMed ID: 31308578 [TBL] [Abstract][Full Text] [Related]
12. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia. Li H; Rui Q; Ning X; Xu H; Gu N Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787 [TBL] [Abstract][Full Text] [Related]
14. What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review. Baeza I; Fortea A; Ilzarbe D; Sugranyes G Paediatr Drugs; 2023 Mar; 25(2):135-149. PubMed ID: 36662369 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder]. Benabarre A; Castro P; Sánchez-Moreno J; Martínez-Arán A; Salamero M; Murru A; Franco C; Vieta E Actas Esp Psiquiatr; 2009; 37(3):143-7. PubMed ID: 19533426 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study. Barrio P; Batalla A; Castellví P; Hidalgo D; García M; Ortiz A; Grande I; Pons A; Parellada E Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986 [TBL] [Abstract][Full Text] [Related]
17. Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review. Pacchiarotti I; Tiihonen J; Kotzalidis GD; Verdolini N; Murru A; Goikolea JM; Valentí M; Aedo A; Vieta E Eur Neuropsychopharmacol; 2019 Apr; 29(4):457-470. PubMed ID: 30770235 [TBL] [Abstract][Full Text] [Related]
18. Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens. Fu DJ; Bossie CA; Kern Sliwa J; Ma YW; Alphs L Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):101-9, 109A. PubMed ID: 23446197 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics. Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593 [TBL] [Abstract][Full Text] [Related]
20. Potential benefits of combining two long-acting injectable antipsychotic: a retrospective study. Kenar ANI; Unal GA; Mert A; Ay AM Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8609-8613. PubMed ID: 37782176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]